Redox Limited (ASX:RDX)
Australia
· Delayed Price · Currency is AUD | Market Cap | 1.77B |
| Revenue (ttm) | 1.29B |
| Net Income (ttm) | 80.68M |
| Shares Out | 525.08M |
| EPS (ttm) | 0.15 |
| PE Ratio | 22.05 |
| Forward PE | 20.85 |
| Dividend | 0.13 (3.70%) |
| Ex-Dividend Date | Mar 3, 2026 |
| Volume | 392,205 |
| Average Volume | 503,572 |
| Open | 3.350 |
| Previous Close | 3.380 |
| Day's Range | 3.290 - 3.370 |
| 52-Week Range | 2.015 - 3.520 |
| Beta | -0.37 |
| RSI | 53.42 |
| Earnings Date | May 20, 2026 |
About Redox
Redox Limited supplies and distributes chemicals, ingredients, and raw materials in Australia, New Zealand, the United States, and internationally. It offers antioxidants, proteins and fibres, leaving agents, acidity regulator, sweeteners, thickeners, stabilisers and gums, vitamins, amino acids, mineral salts, preservatives, phosphates, humectants, essential and vegetable oils, herb and spice extracts, natural colours, emulsifier, dairy products, wine and brewing, cleaning and sanitation, specialities, additives, chemicals, emollients, emulsifi... [Read more]
Financial Performance
In fiscal year 2025, Redox's revenue was 1.24 billion, an increase of 9.36% compared to the previous year's 1.14 billion. Earnings were 77.10 million, a decrease of -14.56%.
Financial StatementsNews
Redox Earnings Call Transcript: H1 2026
Sales grew 6.6% to AUD 674 million, with strong industrial and food segment gains and robust North American performance. Gross profit and EPS rose, supported by disciplined costs and a strong net cash position, while management anticipates upward pricing pressure and continued M&A activity.
Redox Transcript: AGM 2025
The meeting highlighted strong financial growth, a robust dividend, and successful acquisitions expanding both product range and geographic reach. Board governance, ESG commitments, and strategic focus on North America were emphasized, with all resolutions passed and key risks around market conditions and culture addressed.
Redox Earnings Call Transcript: H2 2025
FY 2025 delivered 9.4% revenue growth and strong cash generation despite subdued demand and cost pressures. Three acquisitions and organic expansion drove segment growth, with July 2025 sales and volumes up 13% year-over-year, signaling a positive start to FY 2026.
Redox Earnings Call Transcript: H1 2025
Revenue grew 8.6% year-over-year with robust volumes, while gross margin eased to 21.6% but remained within the historical range. Strong cash position and recent acquisitions support future growth, with stable outlook and continued above-average volumes expected.
Redox Transcript: AGM 2024
The meeting reviewed strong FY24 results, with higher earnings per share and gross profit margin despite sector headwinds. Strategic expansion in North America and new acquisitions were highlighted, and all resolutions, including director re-election and performance rights, were put to a poll.
Redox Earnings Call Transcript: H2 2024
Volume growth and improved gross margins drove an 11.4% increase in net profit after tax, with strong cash generation and a robust balance sheet. North America expansion, successful acquisitions, and a proprietary CRM system support future growth, though margins are expected to normalize as US and commodity sales rise.